Stocks and Investing Stocks and Investing
Mon, October 31, 2022
[ 12:00 AM ] - WOPRAI
Yuan Zhi Maintained (ATNM) at Strong Buy with Increased Target to $18 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
J. Bruce Chan Maintained (UPS) at Strong Buy and Held Target at $207 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (URBN) at Hold with Increased Target to $24 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Stanley Elliott Maintained (URI) at Strong Buy and Held Target at $400 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
David Gagliano Maintained (VALE) at Buy with Decreased Target to $16 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Jim Duffy Maintained (VFC) at Hold and Held Target at $33 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Bernie McTernan Maintained (VCSA) at Strong Buy with Decreased Target to $140 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Stan Berenshteyn Initiated (VEEV) at Hold and Held Target at $180 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Kelsey Goodwin Initiated (TSVT) at Strong Buy and Held Target at $30 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Mullen Downgraded (TXRH) to Hold and Increased Target to $101 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (UAA) at Buy with Decreased Target to $10 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $100 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Rajat Gupta Upgraded (TRUE) to Buy on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Simon Flannery Maintained (TMUS) at Buy with Increased Target to $180 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
David Barden Maintained (TMUS) at Strong Buy and Held Target at $175 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Matt Olney Maintained (STEL) at Hold with Increased Target to $37 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Kevin Fitzsimmons Downgraded (SMBK) to Hold and Held Target at $33 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Mark Wilde Downgraded (SON) to Sell and Decreased Target to $58 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Nicholas Campanella Maintained (CMS) at Hold with Increased Target to $61 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
John Pancari Upgraded (CFR) to Hold and Increased Target to $160 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Rose Initiated (BFST) at Buy and Held Target at $28 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Yong Maintained (TDOC) at Hold with Decreased Target to $30 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (TEAM) at Hold with Decreased Target to $220 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Carlos De Alba Maintained (TECK) at Buy with Decreased Target to $47 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Jamie Cook Maintained (TEX) at Hold with Increased Target to $47 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (TEX) at Hold with Increased Target to $35 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
James Monigan Maintained (TFII) at Buy with Decreased Target to $100 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Fadi Chamoun Maintained (TFII) at Hold with Decreased Target to $100 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Tessa Romero Downgraded (YMAB) to Sell and Decreased Target to $7 on, Oct 31st, 2022
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (YMAB) at Strong Buy with Decreased Target to $19 on, Oct 31st, 2022

Robert Burns Maintained (YMAB) at Strong Buy with Decreased Target to $19 on, Oct 31st, 2022


Published on 2024-10-27 23:46:07 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy with Decreased Target from $63 to $19 on, Oct 31st, 2022.

Robert, nor any peers, have made any analyst calls on YMAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources